泓博医药
(301230)
| 流通市值：20.00亿 | | | 总市值：36.26亿 |
| 流通股本：5937.17万 | | | 总股本：1.08亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 108,312,854.23 | 204,296,295.47 | 115,498,263.73 | 148,547,002.73 |
| 应收票据及应收账款 | 101,367,767.47 | 86,248,075.13 | 86,168,952.62 | 64,167,025.18 |
| 其中：应收票据 | 871,910.09 | 715,013.32 | 1,310,802.97 | 1,301,552.25 |
| 应收账款 | 100,495,857.38 | 85,533,061.81 | 84,858,149.65 | 62,865,472.93 |
| 应收款项融资 | - | - | 803,762.55 | - |
| 预付款项 | 3,421,367.58 | 2,430,946.79 | 4,576,761.03 | 86,464,698.16 |
| 其他应收款合计 | 5,755,202.51 | 5,055,930.3 | 5,565,555.73 | 6,516,348.27 |
| 存货 | 57,137,195.48 | 61,418,006.89 | 83,059,857.94 | 96,891,150.47 |
| 其他流动资产 | 31,495,304.33 | 31,080,918.3 | 21,937,567.36 | 13,051,050.82 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 701,273,371.03 | 731,324,912.6 | 775,266,232.76 | 865,449,388.67 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 11,990,176 | 10,084,234.98 | 10,000,000 | 8,000,000 |
| 固定资产 | 183,227,598.88 | 187,934,998.79 | 146,249,966.62 | 145,063,561.46 |
| 在建工程 | 204,408,896.24 | 199,979,592.66 | 153,616,729 | 108,844,577.71 |
| 使用权资产 | 176,586,212.5 | 182,313,265 | 188,040,317.5 | 151,004,434.23 |
| 无形资产 | 8,596,909.97 | 8,710,419.61 | 8,543,466.14 | 8,371,672.07 |
| 长期待摊费用 | 150,279,260.4 | 155,332,632.75 | 149,262,636.89 | 65,984,184.54 |
| 递延所得税资产 | 14,197,086.25 | 10,290,504.32 | 14,214,199.58 | 3,517,523.75 |
| 其他非流动资产 | 379,429 | 1,193,362.06 | 38,002,735.95 | 11,961,386.69 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 749,665,569.24 | 755,839,010.17 | 707,930,051.68 | 502,747,340.45 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,450,938,940.27 | 1,487,163,922.77 | 1,483,196,284.44 | 1,368,196,729.12 |
| 流动负债: | | | | |
| 短期借款 | 23,258,158.74 | 15,921,295.25 | 10,010,555.11 | 10,012,836.9 |
| 应付票据及应付账款 | 99,315,130.5 | 114,612,962.7 | 87,880,331.87 | 40,827,322.79 |
| 其中：应付票据 | 3,077,436 | 8,278,970.2 | 18,343,327.3 | 15,131,844.1 |
| 应付账款 | 96,237,694.5 | 106,333,992.5 | 69,537,004.57 | 25,695,478.69 |
| 预收款项 | 1,913,728.01 | 1,951,499.84 | 2,034,050.12 | 1,141,140.3 |
| 合同负债 | 2,304,132.73 | 2,222,525.09 | 1,154,466.69 | 2,054,830.17 |
| 应付职工薪酬 | 22,728,218.78 | 28,803,550.47 | 26,084,529.3 | 21,950,965.16 |
| 应交税费 | 4,320,404.17 | 4,751,997.8 | 1,759,811.8 | 3,408,826.49 |
| 其他应付款合计 | 2,484,154.57 | 3,363,286.32 | 16,092,070.06 | 13,881,364.37 |
| 一年内到期的非流动负债 | 19,501,416.54 | 18,759,919.38 | 20,914,348.29 | 15,275,937.69 |
| 其他流动负债 | 1,049,401.27 | 834,712.21 | 1,341,308.18 | 693,155 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 176,874,745.31 | 191,221,749.06 | 167,271,471.42 | 109,246,378.87 |
| 非流动负债: | | | | |
| 租赁负债 | 166,664,755.35 | 171,673,082.68 | 173,736,954.88 | 141,820,199.93 |
| 预计负债 | 1,152,951.81 | 3,098,653.55 | 3,030,916.14 | 1,857,053.63 |
| 递延所得税负债 | 2,892,867.83 | 3,625,770.95 | 13,310,057.44 | 2,459,486.49 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 170,710,574.99 | 178,397,507.18 | 190,077,928.46 | 146,136,740.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 347,585,320.3 | 369,619,256.24 | 357,349,399.88 | 255,383,118.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 107,622,666 | 107,622,666 | 107,622,666 | 107,622,666 |
| 资本公积 | 798,774,078.45 | 798,774,078.45 | 798,774,078.45 | 798,774,078.45 |
| 减:库存股 | 17,858,707.12 | - | - | - |
| 其他综合收益 | - | - | -12,550.6 | - |
| 盈余公积 | 24,852,529.51 | 24,852,529.51 | 19,909,470.31 | 19,909,470.31 |
| 未分配利润 | 189,963,053.13 | 186,295,392.57 | 199,553,220.4 | 186,507,395.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,103,353,619.97 | 1,117,544,666.53 | 1,125,846,884.56 | 1,112,813,610.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,103,353,619.97 | 1,117,544,666.53 | 1,125,846,884.56 | 1,112,813,610.2 |
| 负债和股东权益合计 | 1,450,938,940.27 | 1,487,163,922.77 | 1,483,196,284.44 | 1,368,196,729.12 |
| 公告日期 | 2024-04-26 | 2024-04-24 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |